Search

Search Constraints

You searched for: Author/Creator Ghazaly, Essam

Search Results

1. A Phase Ib Study of NUC‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC‐08). (3rd December 2020)

2. Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study. Issue 7 (2nd October 2018)

5. Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity. Issue 47 (21st July 2020)

6. Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism. Issue 1 (December 2017)